关注
Amadeo Wals Zurita
Amadeo Wals Zurita
radiation oncology
在 juntadeandalucia.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
Dose painting by means of Monte Carlo treatment planning at the voxel level
E Jiménez-Ortega, A Ureba, A Vargas, JA Baeza, A Wals-Zurita, ...
Physica Medica 42, 339-344, 2017
112017
Tus pacientes también vuelan. Aspectos médicos de la aviación comercial
AG GOROSTIZA, JA Ibáñez, P JARANILLA, AVE Sarrió, A Zurita, ...
Semergen 25 (9), 806-817, 2000
102000
Proposals of models for new formulations of the current complication-free cure (P+) and uncomplicated tumor control probability (UTCP) concepts, and total normal tissue …
T Frometa-Castillo, A Pyakuryal, A Wals-Zurita, A Mesbahi
International Journal of Radiation Biology 96 (7), 847-850, 2020
72020
Biologically effective dose (BED) or radiation biological effect (RBEf)?
T Frometa-Castillo, A Pyakuryal, A Wals-Zurita, A Mesbahi
Recent Techniques and Applications in Ionizing Radiation Research, 17, 2020
52020
Accurate, robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy
E Jiménez-Ortega, A Ureba, JA Baeza, AR Barbeiro, M Balcerzyk, ...
PLoS One 14 (1), e0210549, 2019
52019
The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments
T Frometa-Castillo, A Pyakuryal, G Narayanasamy, A Mesbahi, ...
reports of practical Oncology and radiotherapy 27 (4), 602-609, 2022
32022
Computational simulations of similar probabilistic distributions to the binomial and Poisson distributions
T Frometa-Castillo, A Pyakuryal, A Wals-Zurita, A Mesbahi
Preprints, 2020
32020
The mathematical, probabilistic and computational generators of discrete probabilistic distributions applied to medical physics. MPI Vol 8 No. 3
T Frometa-Castillo, A Pyakuryal, A Wals-Zurita, A Mesbahi
MEDICAL PHYSICS 8 (3), 2020
32020
The use of the normal tissue non-complication probability (NTCP0) in the safety evaluations as a new alternative of assessing the side-effects of the radiation oncology treatments
T Frometa-Castillo, A Pyakuryal, G Narayanasamy, A Wals-Zurita, ...
International Journal of Radiation Biology 99 (4), 656-662, 2023
22023
Computational simulator that calculates tumor control probability in a tumor heterogeneously irradiated for fractionated radiation oncology treatments
T Frometa-Castillo, A Pyakuryal, G Narayanasamy, A Wals-Zurita, ...
Simulation 98 (4), 285-294, 2022
22022
Implications of the Harmonization of [18F]FDG-PET/CT Imaging for Response Assessment of Treatment in Radiotherapy Planning
E Jiménez-Ortega, R Agüera, A Ureba, M Balcerzyk, A Wals-Zurita, ...
Tomography 8 (2), 1097-1112, 2022
12022
Experiencia en la utilización del fentanilo transdérmico en un servicio de Oncología radioterápica.
J Martínez, I Cabrera, A Álvarez, A Zurita, R Generoso, A Mayoral, ...
Clinical & Translational Oncology 5 (6), 2003
12003
The Transformative Potential of Large Language Models in Mining Electronic Health Records Data
AW Zurita, HM del Rio, NUR de Aguirre, CN Navarro, MR Jiménez, ...
medRxiv, 2024.03. 07.24303588, 2024
2024
123 Can machine-learning model predict overall survival in head and neck cancer patients?
MAG Ruiz, AW Zurita
Radiotherapy and Oncology 192, S138-S139, 2024
2024
Clinical impact on the radiotherapy treatment planning of the new EARL FDG-PET/CT accreditation versus the previous EARL1
E Jiménez-Ortega, R Agüera, M Balcerzyk, A Ureba, A Wals-Zurita, ...
Physica Medica 92, S21-S22, 2021
2021
PO-1175 Influence of Charlson comorbidity index in hypofractionated radiotherapy treatment in lung cancer.
MAG Ruiz, VV Barragán, AW Zurita, JJC Rodríguez
Radiotherapy and Oncology 161, S974-S975, 2021
2021
PO-1165 Dosimetric parameters in hypofractionated radiotherapy in NSCLC cohort during SARS-COV-2 pandemia
MAG Ruiz, VV Barragán, AW Zurita, AO Lora, PV Ruiz, NUR de Aguirre, ...
Radiotherapy and Oncology 161, S967, 2021
2021
PO-0947 Indications for chest computed tomography in the extension study of HNC
JP Ibáñez, BQ Ángel, AW Zurita, JS Bejarano
Radiotherapy and Oncology 161, S790, 2021
2021
PO-1181 Hypofractionation in NSCLC as the new standard of care during SARS-CoV-2 pandemia.
VV Barragán, MÁG Ruiz, JJC Rodriguez, PS Silva, JQ Rivero, AW Zurita
Radiotherapy and Oncology 161, S979, 2021
2021
Abstract ID: 177 A robust Monte Carlo treatment planning optimization algorithm for dose painting clinical implementation
E Jiménez-Ortega, A Ureba, AR Barbeiro, M Balcerzyk, ÁP Gallego, ...
Physica Medica: European Journal of Medical Physics 42, 37-38, 2017
2017
系统目前无法执行此操作,请稍后再试。
文章 1–20